Century Therapeutics, Inc. beat EPS estimates 67% of the time across 3 reported quarters (2 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.11 | $-0.17 | -54.5% | Miss |
| Q12026 FY2026 | $-0.15 | $-0.11 | +26.7% | Beat |
| Q42025 FY2025 | $-0.28 | $-0.25 | +10.7% | Beat |
Back to IPSC overview · IPSC holders · IPSC KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.